成都血管瘤哪个医院成都婴儿血管瘤上哪家医院,成都中医怎样治疗{静脉炎},成都治血管畸形病好的医院是哪家,成都血管畸形哪个医院开刀,成都专门治疗精索静脉曲张的医院,成都治疗鲜红斑痣医院排名,成都治疗小腿静脉曲张要多钱

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

The overall quality of a new, model year 2019 vehicle was no better than in 2018, despite the average vehicle price increasing from year to year.In a study released Wednesday by J.D. Power and Associates, it measured the number of problems experienced during the first 90 days of ownership. Based on this standard, the study found 13 brands improved, while 18 worsened. Overall, it found that there were 93 problems per 100 vehicles with new cars. Some models, on average, had more than one problem per vehicle. The study found that Genesis was the best performing brand in 2019 with 63 problems per 100 vehicles. Genesis was followed by Kia with 70 problems per 100 vehicles. The worst performing auto brand was Jaguar with 130 problems per 100 vehicles. “Automakers continue to make progress in areas like infotainment that attract a lot of consumer attention,” said Dave Sargent, Vice President of Global Automotive at J.D. Power. “However, some traditional problems crept up this year including paint imperfections, brake and suspension noises, engines not starting and the ‘check engine’ light coming on early in the ownership experience. Also, more people are having issues with their advanced driver assistance systems, which are critical for building consumer trust in future automated vehicles.”J.D. Power notes that Hyundai Motor Group brands Genesis, Kia and Hyundai has widened the gap in quality. Hyundai ranked third with 71 problems per vehicle. The next best brand is Ford with 83 problems per vehicle. One area of improvement is car's infotainment units, but remains as the most problematic category for new vehicles. Although the quality has not increased among new cars, the price has. Kelley Blue Book found that new car prices increased 1.3 percent from the end of 2017 to the end of 2018. For more information on the study, click 1865

The Supreme Court unanimously held on Wednesday that the 8th Amendment's prohibition on excessive fines applies to state and local governments, in addition to the federal governmentThe opinion was written and delivered from the bench by Justice Ruth Bader Ginsburg, her first opinion issued since her cancer surgery in December.Ginsburg was present for oral arguments in the case, which took place in late November."Like the Eighth Amendment's proscriptions of 'cruel and unusual punishment' and '[e]xcessive bail,' the protection against excessive fines guards against abuses of government's punitive or criminal law-enforcement authority," 654

The UAW-GM contract has been ratified and the strike has officially ended on day 40.United Autoworkers members have ratified a new four-year contract that covers employees at 55 UAW-represented sites across the U.S. Union and management inside the GM world headquarters in Detroit are watching the numbers and the union is reporting out two votes – production and skilled trades. "We delivered a contract that recognizes our employees for the important contributions they make to the overall success of the company, with a strong wage and benefit package and additional investment and job growth in our U.S. operations," said Mary Barra, GM Chairman and CEO. "GM is proud to provide good-paying jobs to tens of thousands of employees in America and to grow our substantial investment in the U.S. As one team, we can move forward and stay focused on our priorities of safety and building high-quality cars, trucks and crossovers for our customers."Big assembly plants in other states have been influencing the vote, with most leaning toward "yes."Workers at the Orion Assembly plant were among the last to have informational meetings and vote Thursday. 1164

The Pentagon notified Congress Monday night that it has authorized the transfer of billion to begin new wall construction along the US-Mexico border, drawing immediate objections from Democratic lawmakers.A Pentagon budget reprogramming notification sent to Capitol Hill on Monday and obtained by CNN indicates that up to billion will go toward building 57 miles of fencing, improving roads and other measures on the southern border.The Department of Defense authorized the Army Corp of Engineers to begin planning and construction for the project Monday night. The department will direct the funds toward 18-foot-high fencing along the Yuma and El Paso sections of the border, according to a letter acting Secretary of Defense Patrick Shanahan sent to Secretary of Homeland Security Kirstjen Nielsen.In February, President Donald Trump declared a national emergency in order to funnel billions of dollars to wall construction. As part of his announcement, he directed the use of counterdrug monies to partially fund new wall construction. Under the national emergency, other funds can also be dedicated to building the wall and related infrastructure, including military construction funds.Monday's announcement was just the first billion the administration is making available for wall funding. The administration said previously it plans to shift an additional .5 billion at some point in the future.These initial counterdrug funds will ultimately flow from the Department of Homeland Security to the Army Corps of Engineers to begin construction.Senate Democrats immediately objected to the transfer of money to build fencing along the southern border to block drug smuggling.Every Democratic senator on the Senate Appropriations Committee's subcommittees on Defense and Military Construction, Veterans Affairs and Related Agencies signed on to a letter written to Shanahan objecting to moving billion in personnel funds to counter drug funds to go toward the wall. The senators say the Pentagon did not seek permission before notifying the committee of the transfer."We strongly object to both the substance of the funding transfer, and to the Department implementing the transfer without seeking the approval of the congressional defense committees and in violation of provisions in the defense appropriation itself," the senators wrote. "As a result, we have serious concerns that the Department has allowed political interference and pet projects to come ahead of many near-term, critical readiness issues facing our military."The letter was signed by Sens. Patrick Leahy, Democrat of Vermont; Dick Durbin, Democrat of Illinois; Jack Reed, Democrat of Rhode Island; Brian Schatz, Democrat of Hawaii; Jon Tester, Democrat of Montana; Patty Murray, Democrat of Washington; Chris Murphy, Democrat of Connecticut; Tammy Baldwin, Democrat of Wisconsin; Dianne Feinstein, Democrat of California; and Tom Udall, Democrat of New Mexico. 2962